The therapeutic potential of mesenchymal stem cells

被引:122
作者
Picinich, Sonia C.
Mishra, Pravin J.
Mishra, Prasun J.
Glod, John
Banerjee, Debabrata
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Pharmacol, New Brunswick, NJ 08903 USA
[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Med, New Brunswick, NJ 08903 USA
[3] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Pediat Oncol, New Brunswick, NJ 08903 USA
关键词
migration; regenerative medicine; stem cells; stromal cell-derived factor-1; tumor targeting;
D O I
10.1517/14712598.7.7.965
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Mesenchymal stem cells (MSCs) are multipotent cells with a number of potential therapeutic applications. At present, they are being used in a clinical trial for the treatment of myocardial infarction and are being studied as a therapy for other vascular disorders. Treatments of neurologic disorders and anticancer therapy with MSCs have progressed in light of the migratory properties of MSCs to brain injury and tumors. The osteogenic potential of MSCs is being exploited in work investigating their use in bone regeneration therapy, and the immunomodulatory function of MSCs is being evaluated as a possible therapy for graft-versus-host disease. Here, the authors review recent work contributing to the knowledge of MSC biology and the advances in gene therapy and tissue regeneration using MSCs.
引用
收藏
页码:965 / 973
页数:9
相关论文
共 61 条
[1]   Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization [J].
Asahara, T ;
Masuda, H ;
Takahashi, T ;
Kalka, C ;
Pastore, C ;
Silver, M ;
Kearne, M ;
Magner, M ;
Isner, JM .
CIRCULATION RESEARCH, 1999, 85 (03) :221-228
[2]   Autologous mesenchymal stem cell transplantation in stroke patients [J].
Bang, OY ;
Lee, JS ;
Lee, PH ;
Lee, G .
ANNALS OF NEUROLOGY, 2005, 57 (06) :874-882
[3]   Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance [J].
Berry, Mark F. ;
Engler, Adam J. ;
Woo, Y. Joseph ;
Pirolli, Timothy J. ;
Bish, Lawrence T. ;
Jayasankar, Vasant ;
Morine, Kevin J. ;
Gardner, Timothy J. ;
Discher, Dennis E. ;
Sweeney, H. Lee .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 290 (06) :H2196-H2203
[4]  
Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO
[5]  
2-F
[6]   Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats [J].
Chen, JL ;
Li, Y ;
Wang, L ;
Zhang, ZG ;
Lu, DY ;
Lu, M ;
Chopp, M .
STROKE, 2001, 32 (04) :1005-1011
[7]   Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow [J].
Colter, DC ;
Class, R ;
DiGirolamo, CM ;
Prockop, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3213-3218
[8]   Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis [J].
Crigler, L ;
Robey, RC ;
Asawachaicharn, A ;
Gaupp, D ;
Phinney, DG .
EXPERIMENTAL NEUROLOGY, 2006, 198 (01) :54-64
[9]   Mesenchymal stem cells reside in virtually all post-natal organs and tissues [J].
da Silva Meirelles, Lindolfo ;
Chagastelles, Pedro Cesar ;
Nardi, Nance Beyer .
JOURNAL OF CELL SCIENCE, 2006, 119 (11) :2204-2213
[10]   Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium - Short- and long-term effects [J].
Dai, WD ;
Hale, SL ;
Martin, BJ ;
Kuang, JQ ;
Dow, JS ;
Wold, LE ;
Kloner, RA .
CIRCULATION, 2005, 112 (02) :214-223